134 related articles for article (PubMed ID: 7884257)
1. [Usefulness of allopurinol for prevention of myocardial reperfusion injury in open heart surgery].
Yamazaki I; Soma T; Ichikawa Y; Iwai Y; Kondo J; Matsumoto A
Nihon Kyobu Geka Gakkai Zasshi; 1995 Jan; 43(1):26-31. PubMed ID: 7884257
[TBL] [Abstract][Full Text] [Related]
2. Allopurinol: kinetics, inhibition of xanthine oxidase activity, and protective effect in ischemic-reperfused canine heart as studied by cardiac microdialysis.
Kuzmin AI; Tskitishvili OV; Serebryakova LI; Kapelko VI; Majorova IV; Medvedev OS
J Cardiovasc Pharmacol; 1995 Apr; 25(4):564-71. PubMed ID: 7596124
[TBL] [Abstract][Full Text] [Related]
3. Allopurinol therapy of ischemic heart disease with infarct extension.
Parmley LF; Mufti AG; Downey JM
Can J Cardiol; 1992 Apr; 8(3):280-6. PubMed ID: 1576562
[TBL] [Abstract][Full Text] [Related]
4. Free radical generation and the role of allopurinol as a cardioprotective agent during coronary artery bypass grafting surgery.
Movahed A; Nair KG; Ashavaid TF; Kumar P
Can J Cardiol; 1996 Feb; 12(2):138-44. PubMed ID: 8605635
[TBL] [Abstract][Full Text] [Related]
5. Allopurinol modulates reactive oxygen species generation and Ca2+ overload in ischemia-reperfused heart and hypoxia-reoxygenated cardiomyocytes.
Kang SM; Lim S; Song H; Chang W; Lee S; Bae SM; Chung JH; Lee H; Kim HG; Yoon DH; Kim TW; Jang Y; Sung JM; Chung NS; Hwang KC
Eur J Pharmacol; 2006 Mar; 535(1-3):212-9. PubMed ID: 16516885
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of perioperative myocardial enzyme changes among congenital, rheumatic and coronary artery diseases].
Chen CC; Shen ZL; Ji SY; Liu ZH; Hu YL
Zhonghua Wai Ke Za Zhi; 2003 Aug; 41(8):600-3. PubMed ID: 14505535
[TBL] [Abstract][Full Text] [Related]
7. [Comparison between intermittent retrograde cold blood cardioplegia and retrograde crystalloid cardioplegia].
Yamazaki I; Yano Y; Kondo J; Matsumoto A; Kurata H; Soma T
Nihon Kyobu Geka Gakkai Zasshi; 1996 Apr; 44(4):467-71. PubMed ID: 8666863
[TBL] [Abstract][Full Text] [Related]
8. [Cardioprotection of recombinant human erythropoietin pretreatment on ischemia-reperfused hearts and mechanism thereof: experiment with rats].
Liu XM; Jia Z; Zhou ZQ; Xu JG
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2463-7. PubMed ID: 18067805
[TBL] [Abstract][Full Text] [Related]
9. Trimetazidine improves recovery during reperfusion in isolated rat hearts after prolonged ischemia.
Ikizler M; Dernek S; Sevin B; Kural T
Anadolu Kardiyol Derg; 2003 Dec; 3(4):303-8. PubMed ID: 14675878
[TBL] [Abstract][Full Text] [Related]
10. [Mechanism of cardioprotection against ischemia/reperfusion injury by valsartan: an experiment with isolated rat hearts].
Zhang YJ; Bai XJ; Qi ZM; Wang HX
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3350-3. PubMed ID: 16409843
[TBL] [Abstract][Full Text] [Related]
11. The myocardial protective effect of adenosine as an adjunct to intermittent blood cardioplegia during open heart surgery.
Liu R; Xing J; Miao N; Li W; Liu W; Lai YQ; Luo Y; Ji B
Eur J Cardiothorac Surg; 2009 Dec; 36(6):1018-23. PubMed ID: 19683936
[TBL] [Abstract][Full Text] [Related]
12. Myocardial reperfusion injury. Role of myocardial hypoxanthine and xanthine in free radical-mediated reperfusion injury.
Abd-Elfattah AS; Jessen ME; Lekven J; Doherty NE; Brunsting LA; Wechsler AS
Circulation; 1988 Nov; 78(5 Pt 2):III224-35. PubMed ID: 3180402
[TBL] [Abstract][Full Text] [Related]
13. A clinical trial of allopurinol (Zyloric) for myocardial protection.
Tabayashi K; Suzuki Y; Nagamine S; Ito Y; Sekino Y; Mohri H
J Thorac Cardiovasc Surg; 1991 Apr; 101(4):713-8. PubMed ID: 2008110
[TBL] [Abstract][Full Text] [Related]
14. [Myocardial protective effect of Shenfu injection in patients undergoing valve replacement].
Wang SD; Yuan L; Jiang Y; Li XQ; Wang XZ
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(33):2316-9. PubMed ID: 18036292
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of heart fatty acid-binding protein as a rapid indicator for assessment of myocardial damage in pediatric cardiac surgery.
Hasegawa T; Yoshimura N; Oka S; Ootaki Y; Toyoda Y; Yamaguchi M
J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1697-702. PubMed ID: 15173726
[TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics of injectable allopurinol in newborns with the hypoplastic left heart syndrome.
McGaurn SP; Davis LE; Krawczeniuk MM; Murphy JD; Jacobs ML; Norwood WI; Clancy RR
Pediatrics; 1994 Dec; 94(6 Pt 1):820-3. PubMed ID: 7970996
[TBL] [Abstract][Full Text] [Related]
17. Allopurinol improves myocardial reperfusion injury in a xanthine oxidase-free model.
Hopson SB; Lust RM; Sun YS; Zeri RS; Morrison RF; Otaki M; Chitwood WR
J Natl Med Assoc; 1995 Jul; 87(7):480-4. PubMed ID: 7636893
[TBL] [Abstract][Full Text] [Related]
18. [The effect of xanthine oxidase inhibitor on hindlimb ischemia-induced thromboxane A2 release].
Sakio H; Okuda C
Masui; 1990 Dec; 39(12):1646-51. PubMed ID: 2098592
[TBL] [Abstract][Full Text] [Related]
19. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
[TBL] [Abstract][Full Text] [Related]
20. Predictors of allograft ischemic injury in clinical heart transplantation.
Kjellman UW; Shariari A; Svensson G; Wiklund L; Bengtsson A; Ekroth R
Scand Cardiovasc J; 2002 Sep; 36(5):313-8. PubMed ID: 12470401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
